Genetic characterization of metastasis and prognosis in high-grade serous ovarian cancer.

被引：0
|
作者：
Kotnik, Emilee N. [1 ]
Spies, Nicholas C. [1 ]
Li, Tiandao [1 ]
Inkman, Matthew [1 ]
Zhang, Jin [1 ]
Martins-Rodrigues, Fernanda [1 ]
Hagemann, Ian S. [1 ]
McCourt, Carolyn K. [1 ]
Thaker, Premal H. [1 ]
Hagemann, Andrea R. [1 ]
Powell, Matthew A. [1 ]
Mutch, David G. [1 ]
Maher, Christopher A. [1 ]
Miller, Christopher A. [1 ]
Fuh, Katherine C. [1 ]
机构：
[1] Washington Univ, St Louis, MO 63110 USA
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2202
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Screening of Critical Genes Involved in Metastasis and Prognosis of High-Grade Serous Ovarian Cancer by Gene Expression Profile Data
    Wang, Ruike
    Du, Xia
    Zhi, Yaqin
    JOURNAL OF COMPUTATIONAL BIOLOGY, 2020, 27 (07) : 1104 - 1114
  • [22] IQGAP3 promotes cancer proliferation and metastasis in high-grade serous ovarian cancer
    Dongol, Samina
    Zhang, Qing
    Qiu, Chunping
    Sun, Chenggong
    Zhang, Zhiwei
    Wu, Huan
    Kong, Beihua
    ONCOLOGY LETTERS, 2020, 20 (02) : 1179 - 1192
  • [23] The high-grade serous ovarian cancer metastasis and chemoresistance in 3D models
    Tadic, Vanja
    Zhang, Wei
    Brozovic, Anamaria
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2024, 1879 (01):
  • [24] VISTA expression is associated with a favorable prognosis in patients with high-grade serous ovarian cancer
    Liju Zong
    Yuncan Zhou
    Ming Zhang
    Jie Chen
    Yang Xiang
    Cancer Immunology, Immunotherapy, 2020, 69 : 33 - 42
  • [25] VISTA expression is associated with a favorable prognosis in patients with high-grade serous ovarian cancer
    Zong, Liju
    Zhou, Yuncan
    Zhang, Ming
    Chen, Jie
    Xiang, Yang
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2020, 69 (01) : 33 - 42
  • [26] Expression of inflammatory biomarkers is associated with prognosis in patients with high-grade serous ovarian cancer
    Brzezinska, Bogna
    Mysona, David
    Richardson, Katherine
    Purohit, Sharad
    Suhner, Jessa
    Vaz, Jennifer
    Johnson, Marian
    Higgins, Robert
    Rungruang, Bunja
    Ghamande, Sharad
    McIndoe, Richard
    GYNECOLOGIC ONCOLOGY, 2023, 176 : S303 - S304
  • [27] CD73 Is Associated with Poor Prognosis in High-Grade Serous Ovarian Cancer
    Turcotte, Martin
    Spring, Kathleen
    Pommey, Sandra
    Chouinard, Guillaume
    Cousineau, Isabelle
    George, Joshy
    Chen, Gregory M.
    Gendoo, Deena M. A.
    Haibe-Kains, Benjamin
    Karn, Thomas
    Rahimi, Kurosh
    Le Page, Cecile
    Provencher, Diane
    Mes-Masson, Anne-Marie
    Stagg, John
    CANCER RESEARCH, 2015, 75 (21) : 4494 - 4503
  • [28] Variance of HRD score from primary to recurrent in high-grade serous ovarian cancer.
    Chen, Xiaoxiang
    Ni, Jing
    Xu, Xia
    Guo, Wenwen
    Zhao, Qian
    Cheng, Xianzhong
    Zhou, Rui
    Gu, Hongyuan
    Chen, Chen
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [29] CTDNA PROFILING TO PREDICT PROGNOSIS AND OPTIMIZE TREATMENT IN HIGH-GRADE SEROUS OVARIAN CANCER
    Oikkonen, Jaana
    Zhang, Kaiyang
    Salminen, Liina
    Huhtinen, Kaisa
    Schulman, Ingrid
    Andersson, Noora
    Carpen, Olli
    Hietanen, Sakari
    Grenman, Seija
    Lehtonen, Rainer
    Hynninen, Johanna
    Farkkila, Anniina
    Hautaniemi, Sampsa
    CLINICAL CANCER RESEARCH, 2019, 25 (22) : 106 - 106
  • [30] Effect of fibroblast heterogeneity on prognosis and drug resistance in high-grade serous ovarian cancer
    Wang, Tingjie
    Tian, Lingxi
    Wei, Bing
    Li, Jun
    Zhang, Cuiyun
    Long, Ruitao
    Zhu, Xiaofei
    Zhang, Yougai
    Wang, Bo
    Tang, Guangbo
    Yang, Jun
    Guo, Yongjun
    SCIENTIFIC REPORTS, 2024, 14 (01):
12345